Helminth Infections & Their Cutaneous Manifestations

Helminth Infections & Their Cutaneous Manifestations

HELMINTH INFECTIONS & THEIR CUTANEOUS MANIFESTATIONS Brittany Grady, DO DISCLOSURES I have no conflicts of interest to declare LEARNING OBJECTIVES: • Describe the cutaneous manifestations of helminth infections • Recognize recent developments and incidence of helminth infections within the United States of America • Evaluate, diagnose, and treat affected patients more knowledgeably and effectively WHAT IS A HELMINTH? • Helminths (worms) are large, multicellular organisms • Often visible to the naked eye • Free-living or parasitic • Belong to 2 different phyla: • Roundworms (Nematodes) • Flatworms (Platyhelminthes) ROUNDWORMS (NEMATODES) • Unsegmented • Each species has 2 different sexes • Contain a body cavity and digestive tract FLATWORMS (PLATYHELMINTHES) • Segmented or unsegmented • Primarily hermaphroditic • Do not have a body cavity • Further subdivided into 2 different classes: • Flukes (Trematodes) • Tapeworms (Cestodes) ROUNDWORM (NEMATODE) INFECTIONS • Cutaneous Larva Migrans • Onchocerciasis • Filariasis • Strongyloidiasis • Trichinosis • Toxocariasis CUTANEOUS LARVA MIGRANS (CLM) • AKA Creeping Eruption • CLM primarily affects people in tropical and subtropical climates, including the SE United States • Caused by animal hookworms, most commonly Ancylostoma braziliense and A. caninum • Eggs are eliminated via animal (cat or dog) feces and larvae mature in the sand/soil • Larvae infiltrate exposed skin surfaces of humans (end hosts) • Confined to the epidermis (lack collagenase) CLM X X X CUTANEOUS LARVA MIGRANS (CLM) • Larval migration through the epidermis (1-2 cm/day) • Clinical features: • Localized, intense pruritus • Linear or serpiginous raised erythematous “tracts” • +/- vesiculation • Most frequent location is distal lower extremities or buttocks • Diagnosis usually made clinically (biopsy rarely helpful) W. Infectious Diseases of the Skin. In: McKee’s Pathology of the Skin 4th ed. Edinburgh: ElsevierGrayson/Saunders; 2012: 761-895 Nelson SA, Warschaw KE. Protozoa and Worms. In: Dermatology 3rd ed. Edinburgh: Elsevier/Saunders; 2012: 1391-1421 www.visualdx.com Grady BE, Baum B. A Classic Case of Cutaneous Larva Migrans. 2013. http://www.consultantlive.com/skin-diseases/content/article/10162/2148906 CUTANEOUS LARVA MIGRANS (CLM) • Self-limited, but patients typically seek medical treatment • Treatment options: • PO Albendazole 400-800mg/day (Peds: 10-15 mg/kg/day) x 3-5 days • PO Ivermectin 12mg (Peds: 150 mcg/kg) x 1 • Topical 10-15% thiabendazole solution or ointment TID x 15 days • Cryotherapy to leading edge of skin tract (often unreliable) ONCHOCERCIASIS • AKA River Blindness • Onchocerciasis primarily affects people in tropical Africa • Caused by Onchocerca volvulus • Transmitted via blood meal of infected black fly (Simulium spp.) • Larvae mature into adult worms in the dermis and subcutis • Mature adult female worms become encapsulated in fibrous tissue (onchocercomas) • Each worm produces hundreds of microfilariae which migrate to the skin, connective tissue, eyes, and lymph nodes Grayson W. Infectious Diseases of the Skin. In: McKee’s Pathology of the Skin 4th ed. Edinburgh: Elsevier/Saunders; 2012: 761-895 Grayson W. Infectious Diseases of the Skin. In: McKee’s Pathology of the Skin 4th ed. Edinburgh: Elsevier/Saunders; 2012: 761-895 www.who.int/intestinal_worms/en ONCHOCERCIASIS • Clinical features: • Onchocercomas- firm, freely mobile subQ nodules often located over bony prominences • Acute papular onchodermatitis chronic onchodermatitis lichenification, atrophy, depigmentation • “Hanging groin”- chronic lymphatic obstruction of inguinal lymph nodes • Progressive sclerosing keratitis can lead to blindness in severe cases • 2nd most common cause of infection-related blindness • Accounts for 0.8% of overall blindness globally www.visualdx.com Nelson SA, Warschaw KE. Protozoa and Worms. In: Dermatology 3rd ed. Edinburgh: Elsevier/Saunders; 2012: 1391-1421 www.visualdx.com Grayson W. Infectious Diseases of the Skin. In: McKee’s Pathology of Nelson SA, Warschaw KE. Protozoa and Worms. In: Dermatology the Skin 4th ed. Edinburgh: Elsevier/Saunders; 2012: 761-895 3rd ed. Edinburgh: Elsevier/Saunders; 2012: 1391-1421 Grayson W. Infectious Diseases of the Skin. In: McKee’s Pathology of the Skin 4th ed. Edinburgh: Elsevier/Saunders; 2012: 761-895 ONCHOCERCIASIS • Treatment options: • DOC: PO Ivermectin 150 mcg/kg x 1 q3-12 months • Treatment continued for worm’s lifetime (10-15 years) • Adjunct: PO Doxycycline 100-200mg/day x 6 weeks • Targets Wolbachia endobacteria that reside within the O. volvulus nematodes • Wolbachia is responsible for inflammation that leads to subsequent protective fibrosis • Nodulectomy: surgical removal of onchocercomas from head/neck reduces the incidence of ocular disease FILARIASIS • AKA Elephantiasis • Filariasis primarily affects individuals in tropical or subtropical regions, including the Caribbean Islands and South America • Caused by Wucheria bancrofti (90% of cases) • Transmitted via bite of infected mosquitoes • Deposited larvae migrate to lymphatic system and develop into adult worms • Adult worms release microfilariae into the bloodstream Cano J, Rebollo MP, Golding N, et al. The Global Distribution and Transmission Limits of Lymphatic Filariasis: Past and Present. Parasites & Vectors. 2014 Oct; 7: 466 www.visualdx.com FILARIASIS • After 10-15 years of infection, the clinical features of chronic disease become evident • Leading cause of permanent disability worldwide • Clinical features: • Acute adenolymphangitis associated with fevers and chills (recurrent) • Chronic lymphedema hypertrophy of skin (hyperkeratotic, verrucous, fibrotic) redundant folds deformity • Secondary bacterial and fungal infections common • Most commonly affected sites: lower extremities and genitalia www.visualdx.com www.visualdx.com James WD, Berger TG, Elston DM. Parasitic Infestations, Stings, and Bites. In: Andrews’ Diseases of the Skin: Clinical Dermatology 11th ed. Edinburgh: Elsevier/Saunders; 2011: 414-447 FILARIASIS • Treatment options: • DOC: PO Diethylcarbamazine 6 mg/kg/day x 12 days • Active against microfilariae, limited effect on adult worms • Adult worm lifespan in host approx. 5-10 years • Adjunct: PO Doxycycline 200mg/day x 4-8 weeks • Targets Wolbachia endobacteria • Supportive care: limb elevation, compression stockings, protection from trauma, NSAIDs STRONGLYLOIDIASIS • AKA Larva Currens • Worldwide distribution, especially in tropical and subtropical regions, including SE United States and Appalachia • Caused by the human parasite Strongyloides stercoralis • Transmitted via direct contact with free-living larvae, usually through contaminated soil • Larvae penetrate skin migrate to intestine to mature into adult worms lay eggs develop into infective larvae in intestine • Infective larvae migrate toward the perianal opening • Penetrate skin Puthiyakunnon S, Boddu S, Li Y, et al. Strongyloidiasis-An Insight into Its Global Prevalence and Management. PLoS Negl Trop Dis. 2014 Aug; 8(8): e3018 www.cdc.gov/par asites STRONGLYLOIDIASIS • Most patients with strongyloidiasis are asymptomatic • Larval migration through skin (up to 10 cm/day) • Clinical features: • Urticarial serpiginous, raised, erythematous “tract” usually located on the buttocks or trunk • Autoinfection can cause the rash to recur for weeks to years • Hyperinfection with Strongyloides- diffuse petechiael “thumbprint purpura” eruption • Seen in immunocompromised individuals • Dermal invasion of a large number of larvae that migrate through vessel walls • High mortality www.cdc.gov/parasi tes www.visualdx.com STRONGLYLOIDIASIS • Recommended to treat all known infected patients, whether symptomatic or not • Consider testing patients at risk prior to initiating immunosuppressive drugs i.e. corticosteroids • Microscopic stool examination • Treatment options: • DOC: PO Ivermectin 0.2 mg/kg/day x 2 days (consider repeating in 2 weeks) • PO Albendazole 400 mg BID x 7 days • PO Thiabendazole 25 mg/kg BID x 2 days (7-10 days for hyperinfection syndrome) TRICHINOSIS • Worldwide distribution, including the United States • Caused by Trichinella spp. (most commonly Trichinella spiralis) • Transmission via ingestion of larva-containing cysts in raw or undercooked meat • Ingested larvae invade small bowel and mature into adult worms • Adult female worms release larvae that migrate to striated muscle and encyst (may remain viable for several years) • Disease severity categorized as light (1-10 ingested larvae), moderate (50-500 ingested larvae), or severe (>1000 ingested larvae) www.visualdx.com TRICHINOSIS • Pigs are the most common source of human infection • Typically from consumption of home-prepared sausage or undercooked wild game in the U.S. • Worldwide incidence has declined dramatically in past 2-3 decades • Improved pig-raising practices • Improved inspection processes • Commercial and home freezing of pork • Public awareness of danger of eating undercooked meats www.cdc.gov/para sites www.cdc.gov/parasites TRICHINOSIS • Nonspecific GI symptoms occur first (1-2 days post consumption) • Classic symptoms occur within 2 weeks of eating contaminated meat • Clinical features: • Myalgias (approx. 90% cases) • Periorbital edema • Nonpruritic morbilliform exanthem (uncommon) • Subungual splinter hemorrhages • Rare, severe cases may affect CNS, heart, and/or lungs death www.visualdx.com www.visualdx.com TRICHINOSIS • Self-limited if mild disease • Treatment options: • PO Corticosteroids- Prednisone 40-60 mg/day until symptoms

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    93 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us